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VascuWHAT THIS PAPER ADDS
A type 2 endoleak (T2EL) following endovascular aneurysm repair (EVAR) is associated with an increased need
for secondary intervention and presumed risk of rupture, thus analysing the impact of an isolated T2EL on
mortality is necessary. After an 11 year follow up, survival in patients who underwent a secondary intervention
for T2EL was not better than those who were treated conservatively. Most importantly, this study highlights the
need for a conservative approach and for high quality prospective studies to better understand the natural
course of T2EL, and to guide the direction of their management.Objective: The aims of the present study were to examine the impact of type 2 endoleaks (T2EL) on overall
survival and to determine the need for secondary intervention after endovascular aneurysm repair (EVAR).
Methods: A multicentre retrospective cohort study in the Netherlands was conducted among patients with an
infrarenal abdominal aortic aneurysm (AAA) who underwent EVAR between 2007 and 2012. The primary
endpoint was overall survival for patients with (T2ELþ) or without (T2EL-) a T2EL. Secondary endpoints were
sac growth, AAA rupture, and secondary intervention. KaplaneMeier survival and multivariable Cox regression
analysis were used.
Results: A total of 2 018 patients were included. The median follow up was 62.1 (range 0.1 e 146.2) months. No
difference in overall survival was found between T2ELþ (n ¼ 388) and T2EL- patients (n ¼ 1630) (p ¼ .54). The
overall survival estimates at five and 10 years were 73.3%/69.4% and 45.9%/44.1% for T2ELþ/T2EL- patients,
respectively. Eighty-five of 388 (21.9%) T2ELþ patients underwent a secondary intervention. There was no
difference in overall survival between T2ELþ patients who underwent a secondary intervention and those
who were treated conservatively (p ¼ .081). Sac growth was observed in 89 T2ELþ patients and 44/89
patients (49.4%) underwent a secondary intervention. In 41/44 cases (93.1%), sac growth was still observed
after the intervention, but was left untreated. Aneurysm rupture occurred in 4/388 T2EL patients. In Cox
regression analysis, higher age, ASA classification, and maximum iliac diameter were significantly associated
with worse overall survival.
Conclusion: No difference in overall survival was found between T2ELþ and T2EL- patients. Also, patients who
underwent a secondary intervention did not have better survival compared with those who did not undergo a
secondary intervention. This study reinforces the need for conservative treatment of an isolated T2EL and the
importance of a prospective study to determine possible advantages of the intervention.Keywords: Aortic aneurysm, Abdominal, Endoleak, Endovascular procedures
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lower mortality risk, fewer complications, and a shorter
length of hospital stay than open surgical repair.2e4 How-
ever, EVAR can also entail graft related complications and
subsequent interventions. The most prevalent indications
for secondary intervention after EVAR are endoleaks.5 Type
2 endoleaks (T2ELs) occur after EVAR in 16% e 50% of
patients, and comprise approximately half of all endo-
leaks.6e8 T2ELs appear when retrograde blood flow from
aortic side branches pressurises the aneurysm sac.9,10
Approximately 80% e 90% of T2ELs resolve spontaneously
during follow up, but some do not.11 Several studies suggestntion and Survival After Endovascular Aneurysm Repair, European Journal of
2 Sana Mulay et al.that a T2EL is a benign complication,8,12 whereas others
have associated T2EL with adverse late outcomes resulting
in a high secondary intervention rate and significant risk of
aneurysm related complications.13 If there is a T2EL with
aneurysm sac expansion, the 2019 European Society for
Vascular Surgery (ESVS) guideline recommends imaging to
rule out a type 1 or a type 3 endoleak.14 Current guidelines
recommend conservative treatment for T2EL; however, if
the aneurysm sac increases by more than 10 mm, second-
ary intervention is recommended.14
The present study describes the experience with T2ELs
after EVAR in 16 medical centres in the Netherlands over an
11 year follow up period. Analysing the long term effects of
T2ELs using a large dataset may lead to greater consensus
about treatment protocols and may give direction to man-
agement of T2ELs.
MATERIALS AND METHODS
Study design and setting
This was a multicentre retrospective cohort study of all
consecutive patients who underwent elective EVAR be-
tween January 2007 and January 2012 at 16 medical centres
in the Netherlands. Both academic and teaching hospitals
were included. This study was carried out in accordance
with the STROBE statement,15 and was approved by the
Medical Ethics Review Committee of the Amsterdam Uni-
versity Medical Centres, location Academic Medical Centre,
Amsterdam, the Netherlands. The opt out recruitment
method was used, which gave potential participants the
option to object to participation within four weeks. The
Medical Research Involving Human Subject Act (WMO) did
not apply to this study. This was confirmed by the Medical
Ethics Review Committee of the Amsterdam University
Medical Centres, location Amsterdam Medical Centre. This
study was conducted according to the General Data Pro-
tection Regulation (AVG 2016). All medical files were
reviewed by two independent reviewers (SM, AG). Data
were stored and analysed anonymously.
Participants
Data from 2 279 patients who underwent elective EVAR
without chimneys or fenestrations between 2007 and 2012
were collected retrospectively and recorded in a database.
The criterion for inclusion in the study was surgery for an
asymptomatic or symptomatic non-ruptured infrarenal
aortic or aorto-iliac aneurysm. The study excluded patients
with ruptured aneurysms, isolated iliac aneurysms, and
patients with a type 1, 3, or 4 endoleak. If patients had T2EL
detected during follow up, but another endoleak (type 1, 3,
or 4) before rupture, these patients were excluded. Also,
those who did not undergo computed tomography angi-
ography (CTA) scanning within 90 days after the initial
operation were excluded.Please cite this article as: Mulay S et al., Type 2 Endoleak With or Without Interve
Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2021.01.017Data collection
Data were collected from patient medical records and
included the following baseline and anatomical variables:
age, sex, pre-operative AAA diameter, ASA classification,
type of endograft, neck length, and maximum iliac artery
diameters. Patients were divided into two groups: with or
without T2EL (T2ELþ and T2EL-).Endpoints
The primary endpoint was overall survival for T2ELþ and
T2EL- patients. Secondary endpoints were secondary in-
terventions, aneurysm sac growth, and rupture. Mortality
data were ascertained by record linkage between the study
population and the Netherlands national causes of death
register.Definitions
An isolated T2EL was defined as a T2EL without signs of any
additional endoleak during the follow up period and was
subdivided into two groups: early and late onset. An early
onset of T2EL was diagnosed at the first post-operative CTA
within 90 days of the primary procedure, and a late onset
T2EL was one identified subsequent to the initial post-
operative CTA. Sac growth was defined as aneurysm sac
diameter growth of 5 mm compared with the most recent
follow up imaging, or as a change in sac diameter of >5 mm
when compared with the first post-operative AAA diam-
eter.16 Each centre followed their local surveillance protocol
(Table S1). Secondary intervention was defined as any
additional procedure performed during follow up, for an
aneurysm related complication, that was required following,
and related to, the initial aortic repair. Secondary in-
terventions were divided into two groups: endovascular and
open approaches. The 30 day mortality was defined as
death from any cause within 30 days after EVAR. All cause
mortality was expressed as all deaths that occurred in the
study population during the follow up period, regardless of
cause.Statistical analysis
Nominal variables are presented in numbers (%) and
continuous variables as mean and standard deviation (SD),
or median and interquartile range (IQR) depending on
whether they followed a normal distribution. The Shapiroe
Wilk test was used to assess normality. Patients were
grouped according to the presence or absence of T2EL.
Demographic and clinical characteristics were compared
between T2ELþ and T2EL- groups by chi square or Fisher’s
exact tests as appropriate for nominal variables, whereas
continuous variables were compared between the two
groups by the independent sample t test or ManneWhitney
U test, depending on the distribution. Survival analysis wasntion and Survival After Endovascular Aneurysm Repair, European Journal of
Table 1. Baseline characteristics of patients with infrarenal abdominal aortic aneurysm (AAA) who underwent endovascular
aneurysm repair between 2007 and 2012
Characteristics Missing values Type 2 endoleak (n [ 388; 19.2%) No endoleak (n [ 1 630; 80.8%) p value
Male sex 0 331 (85.3) 1470 (90.2) .004
Age e y 0 74.8  10.8 74.9  9.9 .86
AAA diameter e cm 3 6.0  1.0 6.0  1.3 .44
ASA classification 0 .54
ASA I 4 (1.0) 14 (0.9)
ASA II 164 (42.3) 651 (40.0)
ASA III 201 (51.8) 848 (52.0)
ASA IV 18 (4.6) 110 (6.7)
ASA V 1 (0.3) 2 (0.1)
Unknown 0 5 (0.3)
Endograft 0 <.001
Zenith Flex; Cook 132 (34.0) 589 (36.1)
Endurant; Medtronic 115 (29.6) 620 (38.0)
Excluder; Gore 72 (18.6) 188 (11.5)
Talent; Medtronic 31 (8.0) 99 (6.1)
Powerlink; Endologix 5 (1.3) 6 (0.4)
Anaconda; Vascutek 2 (0.5) 6 (0.4)
Aptus; Aptus endosystems 7 (1.8) 6 (0.4)
Other 1 (0.3) 8 (0.5)
Unknown 23 (5.9) 108 (6.6)
Neck length e cm 599 3.0  2.6 3  1.6 .31
Maximum iliac diameter e cm 765 1.9  1.9 1.7  3.3 .41

















Impact of Type 2 Endoleaks on Survival After EVAR 3performed by the KaplaneMeier method, and the log rank
test was used to compare subgroups. Univariable and
multivariable analyses were performed using Cox regression
analysis to identify independent factors associated with
overall survival. Only variables with a p value < .2 on uni-
variable analysis were entered into the multivariable Cox
regression model. Variables entered into the models
included age, sex, pre-operative AAA diameter, ASA classi-
fication, endograft type, neck length, largest maximum
diameter of both iliac arteries, and sac growth. Complete
case analysis was performed in the regression analysis. To
check the violation of the proportionality hazard assump-
tion, a log-log plot for the hazard ratio over time was per-
formed. Multiple imputation by predictive mean matching
(PMM) based on 10 imputation sets was used as a sensi-
tivity analysis to account for missing baseline variables. The
threshold for statistical significance was set at a p value 
.05. All statistical analyses were performed using SPSS 26.0
software (IBM Corp., Armonk, NY, USA).20
0
0
388 367 351 331 304 285 245 191 121 66 32 9
1 630 1 509 1 405 1 318 1 233 1 137 1 013 785 515 324 177 65
12 24 36 48 60 72 84 96 108 120 132 144








Figure 1. Cumulative KaplaneMeier estimate of effect of type 2
endoleak (T2EL) on overall survival of 2018 patients with endo-
vascular aneurysm repair (EVAR). Survival did not differ between
those with or without a T2EL (p ¼ .54, log rank test).RESULTS
Baseline demographics and clinical characteristics
From 2007 to 2012, 2 279 patients underwent EVAR. After
applying the exclusion criteria, a total of 2 018 patients
were included for analysis. The mean (SD) age at EVAR was
74.9 years (10.1) and the majority of patients were male
(89.2%). Baseline demographics and clinical characteristics
stratified by T2EL status are listed in Table 1. No endoleak
was identified in 1 630 patients (80.8%), and an isolated
T2EL was found in 388 patients (19.2%). The median followPlease cite this article as: Mulay S et al., Type 2 Endoleak With or Without Interve
Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2021.01.017up duration was 62.1 months (IQR 59.9; range 1.2 e 146.2)
in the T2ELþ group, and 59.7 months (IQR 61.7; 0.1 e
143.9) in the T2EL- group.Outcome
The 30 day mortality for the study cohort was 1.3% (26/2
018). The overall survival estimates were 95.1%, 73.3%, and
45.9% at 1, 5, and 10 years, respectively, for T2ELþ patients
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Figure 2. Cumulative KaplaneMeier estimate of effect of sec-
ondary intervention on overall survival after endovascular aneu-
rysm repair (EVAR) in subgroup of 388 patients with type 2
endoleak (T2EL). Survival did not differ between those with or
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Figure 3. Cumulative KaplaneMeier estimate of effect of early
and late onset type 2 endoleak (T2EL) after endovascular aneu-
rysm repair (EVAR) on overall survival of 388 T2ELþ patients.
Survival was worse for early onset T2EL patients (p ¼ .019, log
rank test).
4 Sana Mulay et al.patients. Overall survival did not differ between the groups
(p ¼ .54) (Fig. 1). This was also confirmed by multivariable
analysis. In total 197/388 (50.9%) patients in the T2ELþ
group died and 857/1 630 (52.6%) in the T2EL- group died
(p ¼ .55). In addition, there was no difference in overall
survival between T2ELþ patients who had a secondary
intervention for T2EL, and those who did not (p ¼ .081)
(Fig. 2). The median follow up duration in the T2ELþ group
who underwent a secondary intervention was 63.8 (IQR
47.5; range 2.0 e 135.5) months, and 59.6 (IQR 63.5; range
1.2 e 146.2) months in the T2ELþ group who did not un-
dergo a secondary intervention. When comparing the
T2ELþ and T2EL- groups: age, ASA classification, type ofTable 2. Univariable and multivariable analysis of patients with or
abdominal aortic aneurysm (AAA)
Univariab
Hazard ra
Age e y* 1.069 (1.0
ASA classification
ASA I/II (1)* Reference
ASA III (2) 1.223 (1.0
ASA IV/V (3) 1.959 (1.5
Endograft
Zenith Flex (Cook) (1) Reference
Talent (Medtronic) (2) 1.004 (0.7
Endurant (Medtronic) (3) 0.801 (0.6
Excluder (Gore) (4) 0.920 (0.7
Other (5) 0.947 (0.7
AAA diameter e cm 1.128 (1.0
Maximum iliac diameter e cm * 1.170 (1.0
Sac growth 0.944 (0.7
ASA ¼ American Society of Anesthesiologists; CI ¼ confidence interval.
* Variables significantly related to mortality in multivariable analysis.
Please cite this article as: Mulay S et al., Type 2 Endoleak With or Without Interve
Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2021.01.017endograft, AAA diameter, neck angulation, maximum iliac
diameter, and sac growth were independently associated
with death in univariable analysis. In multivariable Cox
regression analysis, age, ASA classification, and the
maximum diameter of iliac arteries remained statistically
significantly associated with death (Table 2). The Cox pro-
portional hazard assumption was met (Appendix S2,
supporting information).Type 2 endoleak characteristics
A total of 388 patients with an isolated T2EL were further
categorised as early or late onset T2EL. Two hundred and
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Figure 4. Cumulative KaplaneMeier estimate of effect of sac
growth on overall survival stratified by secondary intervention
status for 89 patients with type 2 endoleak (T2EL) and sac growth
after endovascular aneurysm repair (EVAR). Survival did not
differ between those T2EL patients with sac growth with or
without intervention (p ¼ .11, log rank test).
Impact of Type 2 Endoleaks on Survival After EVAR 5T2EL. The mean age (SD) of the early onset T2EL group was
74.4 years (7.7) compared with 72.6 (8.5) years in the late
onset T2EL group (p ¼ .039). Most of the early onset T2EL
cases were resolved by the end of follow up (197/268,
74.0%). In the late onset T2EL group, 85/120 (71.0%) of
cases had resolved by the end of follow up. In addition,
fewer interventions were performed in the early onset T2EL
group 44/268 (16.4%) than in the late onset T2EL group 41/
120 (34.2%). Survival of patients with early onset T2EL was
worse than that of patients with a late onset T2EL (p ¼
.019) (Fig. 3). Sac growth was identified in 49/268 (18.0%)
patients in the early onset T2EL group and in 40/120
(33.0%) patients in the late onset T2EL group. One aneu-
rysm rupture was observed in the early onset T2EL group,
and three in the late onset T2EL group.
Secondary interventions
Secondary interventions were undertaken in 249 of 2 018
patients. A total of 223 patients (11.1%) underwent one
secondary intervention, and 26 (1.3%) underwent multiple
interventions. Eighty-five of 388 (22.0%) patients in the
T2ELþ group underwent a secondary intervention
compared with 164 of 1 630 (10.0%) patients in the T2EL-
group (p < .001). The median time to secondary interven-
tion in the T2ELþ group was 32.3 months (IQR 38.1; range
0.1 e 130.3) and in the T2EL- group 12.8 months (IQR 48.0;
range 0.03 e 141.7). In 55 of the 85 T2ELþ patients, an
endoleak was the indication for the secondary intervention.
In the remaining 303 of 388 T2ELþ patients the T2EL was
managed conservatively. In 221/303 (72.9%) cases the T2ELPlease cite this article as: Mulay S et al., Type 2 Endoleak With or Without Interve
Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2021.01.017had spontaneously resolved by the end of follow up, and in
56 patients a recurrent endoleak was identified.
Sac growth
Sac growth was observed in 152/2 018 (7.5%) patients. Sac
growth was seen in 89/388 (23%) T2ELþpatients compared
with 63/1 630 (3.9%) of T2EL- patients (p < .001). Forty-
four T2ELþ patients with sac growth underwent a sec-
ondary intervention. In 41/44 patients (93.2%) sac growth
continued after secondary intervention but was left un-
treated. Survival analysis in the subgroup of patients with
sac growth showed that there was no difference in overall
survival for patients who did or who did not undergo a
secondary intervention (p ¼ .11) (Fig. 4).
Ruptures
The number of aneurysm ruptures in the study cohort was
17/2 018 (0.8%). Aneurysm rupture occurred in four of 388
(1.0%) T2ELþ patients, of whom three patients had sac
growth. In two patients it was decided not to intervene and
to provide palliative care, and in two cases surgical treat-
ment was performed. One patient was treated successfully
by endovascular repair and one patient was treated un-
successfully by open repair and died within 24 hours after
surgery. Ruptures occurred within 18.5 e 130.3 months
after EVAR. The median time to rupture was 64.8 months
(IQR 59.7; range 18.5 e 130.3) for the entire cohort. The
mean (SD) aneurysm diameter at time of rupture was 7.1
cm (1.7). In patients with AAA rupture the overall mortality
was 11/17 (64.7%).
DISCUSSION
This study has highlighted ongoing uncertainties in man-
agement of T2ELs and aimed to investigate both the impact
of T2EL on overall survival and the need for intervention
after T2EL. Important findings regarding T2EL after EVAR
were examined in further detail: 1) the incidence of an
isolated T2EL in the present study was 17%, 2) no difference
in overall survival was identified between patients with or
without a T2EL, and no difference in overall survival was
observed between patients with a T2EL who underwent a
secondary intervention and those who did not undergo
secondary intervention, 3) survival in patients with an early
onset T2EL was worse than that of patients with a late
onset T2EL.
The incidence of T2ELs in the present study was consis-
tent with the incidence in previously published arti-
cles.8,17,18 Patients in the present cohort were followed for
a median of 62.1 months (IQR 59.9; range 0.1 e 146.2),
which was longer than other studies in the same
field.13,16,18 Evidence suggests that T2EL might disappear
spontaneously, and that in many other cases there is no
aneurysm sac growth with its related risk of complica-
tions.18 The present study showed aneurysm sac growth in
89 of 388 patients with an isolated T2EL, which is lowerntion and Survival After Endovascular Aneurysm Repair, European Journal of
6 Sana Mulay et al.than in similar studies.16 A possible explanation for this is
that only patients with an isolated T2EL were included.
Walker et al. also included patients with an additional
endoleak (type 1,3,4) in this number. Although sac growth
was identified in 22.9% of the T2EL patients, no difference
in mortality was observed between T2ELþ and T2EL- pa-
tients during follow up. Similar findings were found in a
multicentre EVAR registry, which stated that overall survival
was unaffected by the presence of a type II endoleak.16 This
small difference in survival between T2ELþ and T2EL- pa-
tients might be explained as the group in which no endo-
leak was identified consisted of patients in whom other
abnormalities were seen (outflow obstruction, endotension,
endograft migration or endograft infection).
In this study, an isolated T2EL was found to be associated
with a greater risk of sac growth and secondary interven-
tion. This is in line with the recently published report of the
ENGAGE registry, in which a significantly higher rate of
secondary intervention was seen for T2ELþ patients.8 Un-
fortunately, early intervention to prevent T2EL is rarely
carried out and the main question of whether secondary
intervention increases the chance of survival remains
unanswered. In the present study, no difference in overall
survival was demonstrated between T2ELþ patients who
underwent a secondary intervention and those who did not.
Secondary interventions tended to be unsuccessful in pa-
tients with aneurysm sac growth. These findings were
consistent with previous studies showing that survival in
patients who underwent a secondary intervention for sac
growth was not better than in patients treated conserva-
tively.16,19 An important issue to address is that it might be
possible that T2ELþ patients in this study are subject to
secondary intervention for progressive loss of seal and not
for fixing the endoleak. Unfortunately, the type of inter-
vention could not be determined in the present study.
Moreover, in the present study, in most cases sac growth
was still present after the secondary intervention. A recent
systematic review did not find any compelling evidence for
the efficacy of secondary intervention for T2EL after EVAR,
and in addition, found that sac growth was still common
after secondary intervention.20
Several studies found T2ELs to follow a benign
course,13,21,22 whereas others reported an increased risk of
rupture and death.23,24 In the present study, T2EL had dis-
appeared spontaneously in 11.0% (n ¼ 221) of patients by
the end of follow up, which was lower than the 17.6% re-
ported in the study by Kim et al.25 This difference might be
attributed to that study reporting only on early onset T2EL
patients. In total 17 ruptures were identified, four ruptures
occurred in the T2ELþ group, of which one rupture was
attributable to a T2EL alone. This is not in line with the
study by Silverberg et al., in which no ruptures were
observed in a cohort of 154 T2EL patients.26 Furthermore,
the present study showed that late onset T2EL was less
likely to have resolved spontaneously by the end of the
follow up period than early onset T2EL. However, patientsPlease cite this article as: Mulay S et al., Type 2 Endoleak With or Without Interve
Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2021.01.017with an early onset T2EL were less likely to survive than
patients with a late onset T2EL. This might be explained as
patients in the early onset group were on average two years
older than those in the late onset group. This was also seen
in the survival curve in which the late endoleak group had a
survival advantage of two years. Secondary intervention
rates were higher in the late onset T2EL group. These
findings were similar to those of previous studies.5,27,28
Another interesting observation is that the maximum
diameter of the iliac arteries was associated with mortality,
which has not been demonstrated in previous studies. The
explanation of this observation remains unclear. The pre-
sent authors hypothesise that this observation is mere
coincidence.
The present authors recommend that in early onset T2EL
cases, secondary intervention should be considered. Addi-
tionally, to better understand the natural course of T2EL,
further research in the form of a prospective design is
advisable. The 2019 ESVS guidelines advise a less strict
follow up protocol in patients without an endoleak and a
good seal, and yearly surveillance in the presence of an
isolated T2EL.14 Based on the present study, a less firm
surveillance schedule might also be safe. If sac growth
concomitant with a T2EL is present, imaging should be
conducted to rule out other causes of growth like type I or
III endoleak.14
There are some limitations to this study. First, as the
diagnosis of a T2EL was based on radiology reports, the
present study may suffer from information bias. It is
possible that some endoleaks were incorrectly categorised
or not detected at all. Diagnostic imaging plays a crucial role
in detecting a T2EL. As CTA and DUS mainly detect large
endoleaks, more sensitive imaging such as blood pool MRA
may be necessary to detect occult T2ELs.29 Furthermore,
residual confounding is possible because of the retrospec-
tive nature of the study. Another limitation of this study
was that some patients were lost to follow up as they were
followed up in a non-participating hospital. In addition,
because in many cases the cause of death was unknown, it
was not possible to study the impact of a T2EL on aneurysm
related mortality. Regardless of these limitations, under-
standing of the impact of T2EL on overall survival and the
need for intervention has improved since the introduction
of the present study, but prospective research on the nat-
ural course of T2ELs and its response to treatment is
required to better understand their natural course.Conclusion
This observational study showed that an isolated T2EL
occurred in 17% of patients undergoing EVAR. It was found
that an isolated T2EL had no impact on overall survival and
that T2EL patients who underwent a secondary intervention
did not have better survival compared with those who did
not undergo a secondary intervention. These results rein-
force the need for conservative treatment of an isolatedntion and Survival After Endovascular Aneurysm Repair, European Journal of
Impact of Type 2 Endoleaks on Survival After EVAR 7T2EL and the importance of a prospective study to deter-
mine the possible advantages of intervention.
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